Prevention and Treatment of Differentiation Syndrome in Patients With Acute Promyelocytic Leukemia

NCT04446806 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Safety and Efficacy

Interventions

DRUG: Ruxolitinib

Sponsor

The First Affiliated Hospital of Soochow University